MMP13 and rheumatoid arthritis: Because MMP13 also promotes cartilage matrix degradation in RA [41], sarilumab not only has a regulatory effect on bone resorption processes but may also have a regulatory function in the inflammatory bone-cartilage interaction of RA patients.